|
Volumn 19, Issue 11, 2001, Pages 2927-2936
|
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: Results of a randomized trial of the european group for blood and marrow transplantation and the united kingdom lymphoma group
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ASPARAGINASE;
CARMUSTINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DOXORUBICIN;
ETOPOSIDE;
HYDROXYUREA;
LOMUSTINE;
MELPHALAN;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISOLONE;
TIOGUANINE;
VINCRISTINE;
ADOLESCENT;
ADULT;
ARTICLE;
AUTOTRANSPLANTATION;
BLOOD TRANSFUSION;
BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
LYMPHOBLASTOMA;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
UNITED KINGDOM;
|
EID: 0035367626
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2001.19.11.2927 Document Type: Article |
Times cited : (99)
|
References (21)
|